Balance Sheet

v3.24.1.1.u2

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 635,365	$ 376,532
Accounts receivable	5,337	700
Prepaid expenses and other current assets	24,902	26,916
Income tax receivable	166	185
Total current assets	665,770	404,333
Operating lease right-of-use assets	133	1,172
Property and equipment, net	462	333
Total assets	666,365	405,838
Current liabilities:
Accounts payable	7,155	1,353
Accrued expenses	41,300	40,421
Current portion of operating lease liabilities	138	1,173
Due to Roivant Sciences Ltd.	15	350
Total current liabilities	48,608	43,297
Operating lease liabilities, net of current portion	0	47
Total liabilities	48,608	43,344
Commitments and contingencies (Note 10)
Stockholders’ equity:
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 145,582,999 shares issued and outstanding at March 31, 2024 and 500,000,000 shares authorized, 130,329,863 shares issued and outstanding at March 31, 2023	14	13
Additional paid-in capital	1,441,518	927,976
Accumulated other comprehensive income	1,908	852
Accumulated deficit	(825,683)	(566,347)
Total stockholders’ equity	617,757	362,494
Total liabilities and stockholders’ equity	666,365	405,838
Series A Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source